Provided by Tiger Trade Technology Pte. Ltd.

Absci Corporation.

9.37
-0.3000-3.10%
Volume:850.18K
Turnover:7.98M
Market Cap:1.61B
PE:-11.71
High:9.66
Open:9.45
Low:9.15
Close:9.67
52wk High:12.06
52wk Low:2.24
Shares:171.61M
Float Shares:156.49M
Volume Ratio:0.47
T/O Rate:0.54%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7999
EPS(LYR):-0.8421
ROE:-57.72%
ROA:-34.10%
PB:6.53
PE(LYR):-11.13

Loading ...

Press Release: Absci to Report Business Updates and Third Quarter 2026 Financial and Operating Results on November 12, 2026

Dow Jones
·
3 hours ago

Absci Price Target Maintained with a $16.00/Share by HC Wainwright & Co.

Dow Jones
·
Yesterday

H.C. Wainwright Sticks to Its Buy Rating for AbSci (ABSI)

TIPRANKS
·
Yesterday

BTIG Remains a Buy on AbSci (ABSI)

TIPRANKS
·
Oct 06

BTIG Keeps Their Buy Rating on AbSci (ABSI)

TIPRANKS
·
Oct 02

Novartis Bets $7.8 Billion On MRNA Beyond Vaccines

Options & Short Sell
·
Oct 02

From Exoskeletons to AI: ChronoScale's Billion-Dollar Pivot

Tech News Roundup
·
Oct 02

H.C. Wainwright Remains a Buy on AbSci (ABSI)

TIPRANKS
·
Oct 01

Analysts Offer Insights on Healthcare Companies: AbSci (ABSI), Summit Therapeutics (SMMT) and Sutro Biopharma (STRO)

TIPRANKS
·
Oct 01

Absci Targets Mid-2027 Start for Phase 2 Storyline Trial of ABS-201 in Endometriosis Pain

Reuters
·
Sep 24

Absci Announces Preliminary Details for Phase 2 Storyline™ Trial of AI-Designed Antibody Abs-201™ for Endometriosis

THOMSON REUTERS
·
Sep 24

Absci Corp - Phase 2 Trial Initiation Anticipated in Mid-2027

THOMSON REUTERS
·
Sep 24

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Sep 23

Absci Price Target Maintained with a $11.00/Share by Needham

Dow Jones
·
Sep 23

Absci Initiated at Outperform by LifeSci Capital

Dow Jones
·
Sep 10

Absci initiated with an Outperform at LifeSci Capital

TIPRANKS
·
Sep 09

Absci price target raised to $15 from $13 at BTIG

TIPRANKS
·
Sep 08

Absci Price Target Raised to $16.00/Share from $13.00 by BTIG

Dow Jones
·
Sep 08

Arm's Haas: AI Could Cure Cancer In Our Lifetime — If The Industry Can Build Enough Chips

AI Industry Frontlines
·
Sep 08

Can Absci’s (ABSI) Low-Frequency Hair Loss Therapy Redefine Its Long-Term Platform Potential?

Simply Wall St.
·
Sep 02